Source-grounded facts extracted from Claritev Corp's SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Claritev Corp reported the first quarter ended March 31, 2026 results: revenue $244.7 million, net income $73.6 million. Guidance reaffirmed.
“Claritev Corporation Reports First Quarter 2026 Results – Q1 2026 Revenues of $244.7 million grew 5.8% compared to Q1 2025 – Net Loss of $73.6 million”
Claritev Corp shareholders approved Approval of the Amendment to the Claritev Corporation 2020 Omnibus Incentive Plan at the 2026-04-29 meeting.
“Proposal 4: Approval of the Amendment to the Claritev Corporation 2020 Omnibus Incentive Plan FOR AGAINST ABSTAIN BROKER NON-VOTE 9,853,010 701,502 8,339 2,628,127”
Claritev Corp shareholders approved Advisory vote to approve the compensation of the Company’s named executive officers at the 2026-04-29 meeting.
“Proposal 3: Advisory vote to approve the compensation of the Company’s named executive officers: FOR AGAINST ABSTAIN BROKER NON-VOTE 9,005,937 1,542,188 14,726 2,628,127”
Claritev Corp shareholders approved Ratification of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for fiscal year 2026 at the 2026-04-29 meeting.
“Proposal 2: Ratification of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for fiscal year 2026: FOR AGAINST ABSTAIN BROKER NON-VOTE 13,184,259 6,243 476 0”
Claritev Corp shareholders approved Election of the four Class III directors at the 2026-04-29 meeting.
“On April 29, 2026, the Company held its Annual Meeting. At the Annual Meeting, the Company’s stockholders voted on the following proposals”
Claritev Corp: Amended and restated bylaws effective February 17, 2025 to reflect the corporate name change to Claritev Corporation (effective 2025-02-17).
“The Company also amended and restated its bylaws (the “Amended and Restated Bylaws”) effective February 17, 2025 to reflect the Name Change.”
Claritev Corp: Corporate name changed from MultiPlan Corporation to Claritev Corporation via certificate of amendment to the Second Amended and Restated Certificate of Incorporation (effective 2025-02-17).
“On February 17, 2025, MultiPlan Corporation (the “Company”) changed its corporate name to Claritev Corporation pursuant to a certificate of amendment (the “Certificate of Amendment”) to its Second Amended and Restated Certificate of Incorporation (the “Certificate of Incorporation”) filed with the Delaware Secretary of State on February 17, 2025 (the “Name Change”).”
Glenn R. August resigned as Director at Claritev Corp.
“On September 6, 2024, Glenn R. August, a member of the Board of Directors (the “Board”) of MultiPlan Corporation (the “Company”), notified the Board that he was resigning from the Board (and its committees on which he serves) effective immediately.”
Douglas Garis was appointed as Executive Vice President, Chief Financial Officer and Treasurer at Claritev Corp.
“On August 1, 2024, the Company and Mr. Garis entered into an employment agreement (the “Garis Employment Agreement”) providing for Mr. Garis’ appointment as Executive Vice President, Chief Financial Officer and Treasurer of the Company on the Transition Date.”
James Head changed role as Strategic Advisor at Claritev Corp.
“On the Transition Date, Mr. Head will remain an employee of the Company and serve as a strategic advisor to the Board of Directors of the Company (the “Board”).”
Michael K. Attal resigned as Director at Claritev Corp.
“On July 30, 2024, Michael K. Attal, a member of the Board of Directors (the “Board”) of MultiPlan Corporation (the “Company”), notified the Board that, in connection with the end of his employment with Hellman & Friedman, LLC, he was resigning from the Board (and its committees on which he serves) effective as of August 1, 2024.”
Jeffrey A. Doctoroff resigned as Executive Vice President, General Counsel and Corporate Secretary at Claritev Corp.
“On May 7, 2024, Jeffrey A. Doctoroff, Executive Vice President, General Counsel and Corporate Secretary of MultiPlan Corporation (“MultiPlan” or the “Company”), provided the Company with notice of his resignation, effective on or about June 30, 2024.”
Claritev Corp reported first quarter ended March 31, 2024 results: revenue $234.5 million, net income Net loss of $539.7 million. Guidance reaffirmed.
“MultiPlan Reports First Quarter 2024 Results – Q1 2024 Revenues of $234.5 million, Net Loss of $539.7 million (including a $519.1 million impairment of goodwill and indefinite-lived intangible assets), and Adjusted EBITDA of $146.8 million”
Claritev Corp shareholders approved Approval of the Amendment to the MultiPlan Corporation 2020 Omnibus Incentive Plan at the 2024-04-24 meeting.
“Proposal 4 – Approval of the Amendment to the MultiPlan Corporation 2020 Omnibus Incentive Plan FOR AGAINST ABSTAIN BROKER NON-VOTE 396,901,531 26,112,485 663,232 29,689,076”
Claritev Corp shareholders approved Advisory vote to approve the compensation of the Company’s named executive officers at the 2024-04-24 meeting.
“Proposal 3 – Advisory vote to approve the compensation of the Company’s named executive officers FOR AGAINST ABSTAIN BROKER NON-VOTE 418,982,031 4,182,664 512,553 29,689,076”
Claritev Corp shareholders approved Ratification of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for fiscal year 2024 at the 2024-04-24 meeting.
“Proposal 2 – Ratification of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for fiscal year 2024 FOR AGAINST ABSTAIN BROKER NON-VOTE 451,268,071 2,011,770 86,483 —”
Claritev Corp shareholders approved Election of the four Class I directors named in the proxy statement to the Company's Board of Directors at the 2024-04-24 meeting.
“Proposal 1 – Election of the four Class I nominees named in the proxy statement to the Company’s Board of Directors NOMINEE FOR WITHHOLD BROKER NON-VOTE Michael K. Attal 409,890,114 13,787,134 29,689,076 Travis S. Dalton 420,942,693 2,734,555 29,689,076 C. Martin Harris 382,910,656 40,766,592 29,689,076 John M. Prince 422,538,790 1,138,458 29,689,076”
Claritev Corp received a nyse deficiency notice notice regarding minimum bid price (rules 802.01C).
“March 28, 2024, MultiPlan Corporation (the “Company”) received a written notice (the “Notice”) from the New York Stock Exchange (the “NYSE”) that it was not in compliance with the continued listing standard set forth in Section 802.01C of the NYSE’s Listed Company Manual (“Section 802.01C”), as the average closing price of the Company’s Class A common stock (the “Common Stock”) was less than $1.00 per share over a consecutive 30 trading-day period ending March 27, 2024. The Notice has no immediate impact on the listing of the Company’s Common Stock on the NYSE, subject to the Company’s complia”
Jerry Hogge was appointed as Executive Vice President and Chief Operating Officer at Claritev Corp.
“On March 7, 2024, MultiPlan Corporation (the "Company" or "MultiPlan") issued a press release announcing the appointment of Jerry Hogge as Executive Vice President and Chief Operating Officer of the Company, effective March 11, 2024.”
Claritev Corp reported Full Year 2024 results: revenue $1,000 million to $1,030 million. Guidance initiated.
“Full Year 2024 Revenues guidance of $1,000 million to $1,030 million”
Claritev Corp reported full year ended December 31, 2023 results: revenue $961.5 million, net income Net loss of $91.7 million.
“Revenues of $961.5 million for full year 2023”
Claritev Corp reported fourth quarter ended December 31, 2023 results: revenue $244.1 million, net income Net loss of $31.4 million. Guidance initiated.
“of any general incorporation language in such filings. --- EX-99.1 (EX-99.1) --- ASE MultiPlan Reports Fourth Quarter and Full Year 2023 Results – Q4 2023 Revenues of $244.1 million, Net Loss of $31.4 million and Adjusted EBITDA of $156.8 million – Full Year 2023 Revenues of $961.5 million, Net Loss of $91.7 million and Adjusted EBITDA of $618.0 million –”
Mark Tabak changed role as Non-Executive Chair of the Board at Claritev Corp.
“Mark Tabak, the Company’s Non-Executive Chair of the Board, will step down from such role, effective as of the Transition Date.”
Dale White changed role as Executive Chair of the Board at Claritev Corp.
“On the Transition Date, Mr. White will remain an employee of the Company and be appointed the Executive Chair of the Board.”
Travis Dalton was appointed as Class I Director at Claritev Corp.
“On the Transition Date, Mr. Dalton will be appointed as a Class I Director of the Board to fill the vacancy created by the Board Size Increase”
Travis Dalton was appointed as President and Chief Executive Officer at Claritev Corp.
“Mr. Dalton will become the Company’s President and Chief Executive Officer succeeding Dale White on or around March 1, 2024.”
Claritev Corp received a nyse delisting notice notice regarding other (rules 802.01D).
“common stock, par value $0.0001 per share (the “Common Stock”), at an exercise price of $11.50 per share, and listed to trade on the NYSE under the symbol “MPLN.WS” (the “Warrants”) and (b) immediately suspend trading in the Warrants due to “abnormally low” trading price levels pursuant to Section 802.01D of the NYSE Listed Company Manual. The Company does not intend to appeal the NYSE’s determination. Trading in the Company’s Common Stock will be unaffected and will continue on the NYSE under the symbol “MPLN”. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, t”
Claritev Corp reported Full Year 2023 results: revenue $960 million to $970 million. Guidance reaffirmed.
“as detailed in the table below. All other guidance items remain unchanged. Financial Metric Prior FY 2023 Guidance Revised FY 2023 Guidance Revenues $950 million to $980 million $960 million to $970 million Adjusted EBITDA 1 $615 million to $635 million $615 million to $625 million Interest expense $325 million to $335 million Cash flow from operations 2 $160 million”
Claritev Corp reported the third quarter ended September 30, 2023 results: revenue $242.8 million, net income Net loss of $24.1 million. Guidance reaffirmed.
“Act, regardless of any general incorporation language in such filings. --- EX-99.1 (EX-99.1) --- RELEASE MultiPlan Reports Third Quarter 2023 Results – Q3 2023 Revenues of $242.8 million, Net Loss of $24.1 million, and Adjusted EBITDA of $152.3 million – Identified potential medical cost savings of approximately $5.8 billion in Q3 2023, up 2% from Q2 2023 and up”
Claritev Corp shareholders approved Approval of the MultiPlan Corporation 2023 Employee Stock Purchase Plan at the 2023-08-04 meeting.
“FOR AGAINST ABSTAIN BROKER NON-VOTE 451,176,575 377,079 15,921 0”
Claritev Corp shareholders approved Election of the four Class II directors and the four Class III directors at the 2023-08-04 meeting.
“CLASS II NOMINEE FOR WITHHOLD BROKER NON-VOTE Glenn R. August 333,393,843 118,175,732 0 Richard A. Clarke 450,707,154 862,421 0 Julie D. Klapstein 449,803,804 1,765,771 0 P. Hunter Philbrick 401,364,647 50,204,928 0 CLASS III NOMINEE FOR WITHHOLD BROKER NON-VOTE Anthony Colaluca, Jr. 449,597,471 1,972,104 0 Michael S. Klein 372,976,358 78,593,217 0 Allen R. Thorpe 391,741,063 59,828,512 0 Dale White 450,191,035 1,378,540 0”
Claritev Corp reported financial results for second quarter ended June 30, 2023.
“On August 2, 2023, the Company issued a press release announcing its financial results for the second quarter ended June 30, 2023.”
William Veghte resigned as Class I Director at Claritev Corp.
“Mr. Prince's election follows the resignation of former Class I director, William Veghte, which resignation was effective December 31, 2023.”
John M. Prince was elected as Class I Director at Claritev Corp.
“the board of directors of MultiPlan (the “ Board ”) elected John M. Prince to the Board as a Class I director, and appointed Mr. Prince to the Audit Committee of the Board, in each case effective June 26, 2023.”
Claritev Corp completed an acquisition involving Benefits Science LLC for $160.0 million (closed 2023-05-08).
“On May 8, 2023, Buyer purchased all of the issued and outstanding equity interests of Benefits Science Technologies (the " Acquisition ") for aggregate consideration of $160.0 million paid at the closing of the Acquisition”
Claritev Corp entered into Unit Purchase Agreement with Benefits Science LLC valued at $160.0 million (effective 2023-05-08).
“On May 8, 2023, Babylon Acquisition Corp., a Delaware corporation and recently formed, wholly owned, indirect subsidiary of MultiPlan (" Buyer "), Benefits Science LLC, a Texas limited liability company (" Benefits Science Technologies " or " BST "), the sellers listed on the signature pages thereto (" Sellers "), MultiPlan, solely for purposes of Section 2.2(a)(ii), MultiPlan, Inc., a New York corporation, solely for purposes of Section 2.2(f)(ii)(x), and WT Representative LLC, solely in its capacity as representative to the Sellers, entered into that certain Unit Purchase Agreement (the " Purchase Agreement ") pursuant to which, on May 8, 2023, Buyer purchased all of the issued and outstanding equity interests of Benefits Science Technologies (the " Acquisition ") for aggregate consideration of $160.0 million paid at the closing of the Acquisition in the form of (i) cash consideration in an aggregate amount of approximately $140.8 million, subject to customary adjustments for working”
Claritev Corp reported the first quarter ended March 31, 2023 results: revenue $236.6 million, net income $0.2 million. Guidance reaffirmed.
“– Q1 2023 Revenues of $236.6 million, Net Income of $0.2 million, and Adjusted EBITDA of $156.3 million –”
Claritev Corp shareholders approved Approval of the MultiPlan Corporation 2023 Employee Stock Purchase Plan at the 2023-04-26 meeting.
“Proposal 4 – Approval of the MultiPlan Corporation 2023 Employee Stock Purchase Plan FOR AGAINST ABSTAIN BROKER NON-VOTE 407,063,041 586,060 135,046 13,437,525”
Claritev Corp shareholders approved Advisory vote to approve the compensation of the Company’s named executive officers at the 2023-04-26 meeting.
“Proposal 3 – Advisory vote to approve the compensation of the Company’s named executive officers FOR AGAINST ABSTAIN BROKER NON-VOTE 402,823,131 4,792,994 168,022 13,437,525”
Claritev Corp shareholders approved Ratification of PriceWaterhouseCoopers LLP as the Company’s independent registered public accounting firm for fiscal year 2023 at the 2023-04-26 meeting.
“Proposal 2 – Ratification of PriceWaterhouseCoopers LLP as the Company’s independent registered public accounting firm for fiscal year 2023 FOR AGAINST ABSTAIN BROKER NON-VOTE 421,056,842 155,825 9,005 —”
Claritev Corp shareholders approved Election of the four Class III directors named in the proxy statement to the Company's Board of Directors at the 2023-04-26 meeting.
“Proposal 1 – Election of the four Class III nominees named in the proxy statement to the Company’s Board of Directors NOMINEE FOR WITHHOLD BROKER NON-VOTE Anthony Colaluca, Jr. 405,891,092 1,893,055 13,437,525 Michael S. Klein 332,158,092 75,626,055 13,437,525 Allen R. Thorpe 353,306,454 54,477,693 13,437,525 Dale White 405,873,180 1,910,967 13,437,525”
Jeff Doctoroff changed role as Executive Vice President, General Counsel and Secretary at Claritev Corp.
“On February 27, 2023, the Compensation Committee of the Board of Directors of the Company (the “Compensation Committee”) approved certain changes to the Company’s compensation arrangement with Jeff Doctoroff in connection with his promotion from Senior Vice President to Executive Vice President.”
Claritev Corp reported the fourth quarter and full year ended December 31, 2022 results: revenue $241.1 million, net income Net loss of $650.1 million. Guidance reaffirmed.
“MultiPlan Reports Fourth Quarter and Full Year 2022 Results – Q4 2022 Revenues of $241.1 million, Net Loss of $650.1 million (including a $662.2 million impairment of goodwill and indefinite-lived intangible assets) and Adjusted EBITDA of $161.5 million”
William L. Veghte resigned as director at Claritev Corp.
“On December 4, 2022, William L. Veghte, a member of the board of directors of the Company (the “Board”), notified the Board that he was resigning as a director of the Company effective on December 31, 2022.”
Claritev Corp reported quarter ended September 30, 2022 results: revenue $250.5 million, net income $19.7 million. Guidance lowered.
“MultiPlan Reports Third Quarter 2022 Results and Updates 2022 Guidance – Q3 2022 Revenues of $250.5 million, Net Income of $19.7 million, and Adjusted EBITDA of $172.2 million”
Michael K. Attal was elected as Director at Claritev Corp.
“Effective August 2, 2022, the Board elected Michael K. Attal to the Board as a Class I director to fill the vacancy resulting from Mr. Emery’s resignation.”
Paul D. Emery resigned as Director at Claritev Corp.
“Paul D. Emery, a member of the Board of Directors (the “Board”) of the Company, notified the Board that, in connection with the end of his employment with Hellman & Friedman, LLC, he was resigning as a director of the Company effective as of the end of the meeting of the Board on August 2, 2022.”
Dale White was appointed as Chief Executive Officer at Claritev Corp.
“the Board, on the recommendation of the Nominating Committee, appointed Mr. White as Chief Executive Officer to succeed Mr. Tabak”
David Redmond departed as Chief Financial Officer at Claritev Corp.
“David Redmond who will retire at the end of 2021”
Jim Head was appointed as Executive Vice President and Chief Financial Officer at Claritev Corp.
“announcing the appointment of Jim Head as Executive Vice President and Chief Financial Officer of the Company, effective November 29, 2021”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.